Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Projecte Benestar 2026: Virtual Reality Program for Healthcare Workers (BENESTAR)

10 de junho de 2026 atualizado por: Jose Ferrer Costa, Badalona Serveis Assistencials

Projecte Benestar 2026: Multicenter Study of the Effectiveness and Implementability of an Immersive Educational Program for Workers in Healthcare Settings

Projecte Benestar 2026 is a multicenter randomized controlled study evaluating a brief immersive educational program delivered through virtual reality for healthcare workers. The program is designed to support emotional well-being, self-care, mindfulness, and emotional regulation in professionals working in healthcare settings.

Participants will be active healthcare or healthcare-support workers from participating centers. They will be randomly assigned to one of two groups. One group will receive the virtual reality program at the beginning of the study, while the other group will continue usual activity and receive the same program later, after a wait-list period.

The main objective is to evaluate whether the program reduces emotional exhaustion, measured with the Maslach Burnout Inventory. Secondary objectives include evaluating changes in depersonalization, personal accomplishment, work engagement, usability, satisfaction, adherence, and tolerability of the virtual reality program.

Visão geral do estudo

Descrição detalhada

This is a multicenter randomized controlled trial with a delayed-start wait-list control design. The study will evaluate Projecte Benestar, an immersive educational virtual reality program designed to support emotional well-being, self-care, mindfulness, emotional regulation, and self-compassion among workers in healthcare settings.

The study population will include active professionals working in participating healthcare organizations, including clinical and non-clinical staff with direct healthcare contact or support functions. Participating institutions may include primary care, hospital, and intermediate care settings. Recruitment will be conducted among eligible workers who voluntarily agree to participate and provide informed consent.

Participants will be randomized in a 1:1 ratio, stratified by center, to one of two study groups. Group A will receive the intervention during the first weeks of the study. Group B will continue usual activity during the initial period and will receive the same intervention after a wait-list period of approximately 6 months. This delayed-start design allows comparison between immediate intervention and usual activity while ensuring that all participants are eventually offered the program.

The intervention consists of eight brief individual virtual reality sessions delivered through autonomous virtual reality headsets. Each session lasts approximately 9 to 15 minutes and combines short educational content with guided immersive practice. The contents include mindfulness, breathing exercises, body scan practices, emotional regulation strategies, the RAIN technique, self-compassion, and a final integration session. Sessions may be delivered in a standard 8-week format with one session per week, or in an intensive 4-week format with two sessions per week, depending on local logistical capacity.

The virtual reality content is fixed and non-adaptive. All participants receive the same sequence of sessions. The application does not require internet connection during use and does not collect automatic data from the device. Participants complete sessions seated in a quiet institutional space, with a local study reference person available for technical support or in case of discomfort.

The primary outcome is change in emotional exhaustion measured with the Maslach Burnout Inventory-Human Services Survey. Secondary outcomes include the other burnout dimensions of depersonalization and personal accomplishment, work engagement measured with the Utrecht Work Engagement Scale, usability measured with the System Usability Scale, participant satisfaction, adherence to the sessions, and tolerability or incidents related to virtual reality use.

Data will be collected at baseline, after the first intervention cycle, at 6 months, after the delayed intervention cycle, and at 12 months. The main analysis will compare changes in outcomes between the immediate intervention group and the wait-list control group, with additional within-group pre-post analyses and follow-up assessments over time.

Tipo de estudo

Intervencional

Inscrição (Estimado)

100

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: José Ferrer Costa, MD, MSc
  • Número de telefone: +34937407482
  • E-mail: jfcosta@bsa.cat

Estude backup de contato

Locais de estudo

    • Barcelona
      • Badalona, Barcelona, Espanha, 08911
        • Recrutamento
        • Badalona Serveis Assistencials
        • Contato:
          • Jose Ferrer, MD, MSc
          • Número de telefone: +34937407482
          • E-mail: jfcosta@bsa.cat
    • Tarragona
      • Valls, Tarragona, Espanha, 43800
        • Recrutamento
        • ABS Valls Urbà | Gerència d'Atenció Primària i a la Comunitat
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

  • Active permanent or temporary staff member at a participating healthcare center where the program is implemented
  • Age 18 years or older
  • Able to understand, accept, and sign the informed consent form
  • Willing to complete the study procedures, attend the planned weekly sessions, and complete the study questionnaires

Exclusion Criteria:

  • Photosensitive epilepsy or history of seizures triggered by visual stimuli
  • Severe motion sickness or previous intolerance to immersive devices
  • Visual or hearing impairment that prevents adequate use of the virtual reality headset

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Immediate Intervention: Projecte Benestar VR Program
Participants randomized to this arm will receive the Projecte Benestar virtual reality educational program during the first intervention period. The program includes 8 individual immersive sessions focused on mindfulness, breathing, body scan, emotional regulation, RAIN, self-compassion, and integration. Sessions last approximately 9 to 15 minutes and may be delivered over 8 weeks or 4 weeks depending on center logistics.
Projecte Benestar is an immersive educational virtual reality program focused on mindfulness, emotional regulation, and self-compassion for workers in healthcare settings. The program includes 8 individual sessions delivered through autonomous virtual reality headsets. Each session lasts approximately 9 to 15 minutes and includes guided audio and immersive 3D content. Sessions may be delivered over 8 weeks or in an intensive 4-week format, depending on local logistics.
Outro: Wait-list Control: Delayed Projecte Benestar VR Program
Participants randomized to this arm will continue usual activity during the initial wait-list control period. After approximately 6 months, they will receive the same Projecte Benestar virtual reality educational program, consisting of 8 individual immersive sessions focused on mindfulness, breathing, body scan, emotional regulation, RAIN, self-compassion, and integration.
Projecte Benestar is an immersive educational virtual reality program focused on mindfulness, emotional regulation, and self-compassion for workers in healthcare settings. The program includes 8 individual sessions delivered through autonomous virtual reality headsets. Each session lasts approximately 9 to 15 minutes and includes guided audio and immersive 3D content. Sessions may be delivered over 8 weeks or in an intensive 4-week format, depending on local logistics.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Change in Emotional Exhaustion Score on the Maslach Burnout Inventory-Human Services Survey
Prazo: Baseline, approximately 4 to 8 weeks, and approximately 7 months
Emotional exhaustion will be assessed using the Emotional Exhaustion subscale of the Maslach Burnout Inventory-Human Services Survey. The subscale includes 9 items scored from 0 to 6, with total scores ranging from 0 to 54. Higher scores indicate greater emotional exhaustion. Changes will be compared between the immediate intervention group and the wait-list control group during the first intervention period, and will also be assessed after the delayed intervention group completes the program.
Baseline, approximately 4 to 8 weeks, and approximately 7 months

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Change in Depersonalization Score on the Maslach Burnout Inventory-Human Services Survey
Prazo: Baseline, approximately 4 to 8 weeks, and approximately 7 months
Depersonalization will be assessed using the Depersonalization subscale of the Maslach Burnout Inventory-Human Services Survey. The subscale includes 5 items scored from 0 to 6, with total scores ranging from 0 to 30. Higher scores indicate greater depersonalization.
Baseline, approximately 4 to 8 weeks, and approximately 7 months
Change in Personal Accomplishment Score on the Maslach Burnout Inventory-Human Services Survey
Prazo: Baseline, approximately 4 to 8 weeks, and approximately 7 months
Personal accomplishment will be assessed using the Personal Accomplishment subscale of the Maslach Burnout Inventory-Human Services Survey. The subscale includes 8 items scored from 0 to 6, with total scores ranging from 0 to 48. Higher scores indicate greater personal accomplishment.
Baseline, approximately 4 to 8 weeks, and approximately 7 months
Change in Vigor Score on the Utrecht Work Engagement Scale-9
Prazo: Baseline, approximately 4 to 8 weeks, and approximately 7 months
Vigor will be assessed using the Vigor dimension of the Utrecht Work Engagement Scale-9. This dimension includes 3 items scored from 0 to 6. The dimension score will be calculated as the mean of the items, ranging from 0 to 6. Higher scores indicate greater vigor, reflecting higher energy and mental resilience at work.
Baseline, approximately 4 to 8 weeks, and approximately 7 months
Change in Dedication Score on the Utrecht Work Engagement Scale-9
Prazo: Baseline, approximately 4 to 8 weeks, and approximately 7 months
Dedication will be assessed using the Dedication dimension of the Utrecht Work Engagement Scale-9. This dimension includes 3 items scored from 0 to 6. The dimension score will be calculated as the mean of the items, ranging from 0 to 6. Higher scores indicate greater dedication, reflecting a stronger sense of significance, enthusiasm, inspiration, pride, and challenge at work.
Baseline, approximately 4 to 8 weeks, and approximately 7 months
Change in Absorption Score on the Utrecht Work Engagement Scale-9
Prazo: Baseline, approximately 4 to 8 weeks, and approximately 7 months
Absorption will be assessed using the Absorption dimension of the Utrecht Work Engagement Scale-9. This dimension includes 3 items scored from 0 to 6. The dimension score will be calculated as the mean of the items, ranging from 0 to 6. Higher scores indicate greater absorption, reflecting being more fully concentrated and deeply involved in work.
Baseline, approximately 4 to 8 weeks, and approximately 7 months
System Usability Scale Score After the Virtual Reality Program
Prazo: After completion of the intervention: approximately 4 to 8 weeks for the immediate intervention group and approximately 7 months for the delayed intervention group
Usability will be assessed using the System Usability Scale, a 10-item questionnaire that provides a global usability score ranging from 0 to 100. Higher scores indicate greater perceived usability of the virtual reality program.
After completion of the intervention: approximately 4 to 8 weeks for the immediate intervention group and approximately 7 months for the delayed intervention group
Participant Satisfaction With the Virtual Reality Program
Prazo: After completion of the intervention: approximately 4 to 8 weeks for the immediate intervention group and approximately 7 months for the delayed intervention group
Satisfaction will be assessed using 2 ad hoc visual analog scale items scored from 0 to 10. The items assess perceived usefulness of the intervention and willingness to recommend the experience to colleagues. Higher scores indicate greater satisfaction.
After completion of the intervention: approximately 4 to 8 weeks for the immediate intervention group and approximately 7 months for the delayed intervention group
Adherence to the Virtual Reality Program
Prazo: From intervention start to intervention completion, approximately 4 to 8 weeks
Adherence will be calculated as the percentage of completed virtual reality sessions out of the total planned sessions. The program includes 8 planned sessions. Higher percentages indicate greater adherence to the intervention.
From intervention start to intervention completion, approximately 4 to 8 weeks

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Tolerability of the Virtual Reality Program
Prazo: Immediately after Sessions 1 through 8 and at intervention completion, up to 8 weeks
Tolerability will be assessed immediately after Sessions 1 through 8 and at intervention completion by recording symptoms related to virtual reality use, including eye fatigue, blurred vision, headache, dizziness, nausea, disorientation, anxiety, or ergonomic discomfort. Symptoms will be rated using an ad hoc 4-point scale from none to severe. Lower scores indicate better tolerability.
Immediately after Sessions 1 through 8 and at intervention completion, up to 8 weeks
Incidence of Virtual Reality-Related Adverse Events or Session Interruptions
Prazo: From intervention start to intervention completion, approximately 4 to 8 weeks
Virtual reality-related incidents will be recorded after each session using a session incident log. Events may include dizziness, cybersickness, headache, anxiety, visual discomfort, or other symptoms leading to session interruption or withdrawal. The outcome will be summarized as the number and proportion of participants with any recorded incident.
From intervention start to intervention completion, approximately 4 to 8 weeks

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Jose Ferrer Costa, MD, MSc, Badalona Serveis Assistencials - Universitat Oberta de Catalunya

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

8 de junho de 2026

Conclusão Primária (Estimado)

1 de dezembro de 2027

Conclusão do estudo (Estimado)

1 de dezembro de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

5 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

10 de junho de 2026

Primeira postagem (Real)

16 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

10 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • BENESTAR-26/085-P
  • 26/085-P (Outro identificador: CEIm IDIAP Jordi Gol Approval Code)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

SIM

Descrição do plano IPD

De-identified individual participant data underlying the results reported in future publications may be shared upon reasonable request to the corresponding author. Data will not be publicly available in an open repository. Access will be subject to approval by the study investigators, institutional data protection requirements, and, where required, a data sharing agreement.

Prazo de Compartilhamento de IPD

De-identified individual participant data and supporting documents will be available beginning 6 months after publication of the main study results and for 5 years thereafter.

Critérios de acesso de compartilhamento IPD

De-identified individual participant data underlying the published results may be shared upon reasonable request to the corresponding author. Access will be limited to researchers who provide a methodologically sound proposal for approved research purposes. Requests will be reviewed by the study investigators and, where required, by the participating institutions. Data will not be made publicly available in an open repository. Access will be subject to applicable data protection requirements and, if required, a data sharing agreement.

Tipo de informação de suporte de compartilhamento de IPD

  • PROTOCOLO DE ESTUDO
  • SEIVA
  • CIF

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever